Summit Therapeutics plc Stock
-
Your prediction
Pros and Cons of Summit Therapeutics plc in the next few years
Pros
Cons
Performance of Summit Therapeutics plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Summit Therapeutics plc | - | - | - | - | - | - | - |
Proteome Sciences | -14.890% | -14.894% | 31.148% | -44.444% | 6.667% | -40.299% | 95.122% |
Oxford BioMedica PLC | 5.360% | 3.509% | -4.839% | -25.316% | 45.082% | -76.242% | -54.731% |
Sareum Holdings plc | 6.690% | 6.695% | 10.390% | -63.571% | -17.073% | -86.027% | - |
News
![3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street: https://g.foolcdn.com/editorial/images/780642/cheering-person-with-laptop.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMnE2YkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--602f57f4672d16108481319d3673d287961d6399/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/cheering-person-with-laptop.jpg?locale=us)
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Never ignore the power of momentum. Sometimes the fastest-moving objects are the ones that keep on racing ahead.
That could be the case with a select group of stocks that have delivered tremendous
![Why Summit Therapeutics Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/778777/scientist-with-head-down.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFdtYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7896f625a371c3cd7c63ca048a9e22c315836b26/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/scientist-with-head-down.jpg?locale=us)
Why Summit Therapeutics Stock Is Sinking Today
Shares of Summit Therapeutics (NASDAQ: SMMT) were sinking 22.6% as of 11:10 a.m. ET on Tuesday. This sell-off follows a similar steep decline of 22% on Friday after Summit revealed late-stage data
![Why Summit Therapeutics Stock Crushed the Market This Week: https://g.foolcdn.com/editorial/images/771209/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd3RsYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e3a6054f96a558a71d63d438c29af9b27f98734c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg?locale=us)
Why Summit Therapeutics Stock Crushed the Market This Week
One exceptional stock in the healthcare sector this trading week was Summit Therapeutics (NASDAQ: SMMT). Buoyed by encouraging news from the lab, the company got an additional boost on Monday with